Biocatalysis enzyme based

In the case of biocatalysis, enzymes [3] and catalytic antibodies [4] have attracted most attention. Since enzymes are inherently the more active catalysts, they have been used most often. Indeed, many industrial processes for the enantioselective production of certain chiral intermediates are based on the application of enzymes, as in the lipase-catalyzed kinetic resolution of an epoxy-ester used in the production of the anti-hypertensive therapeutic Diltiazem [5]. Recently, it has been noted that there seems to be a trend in industry to use enzymes more often than in the past... 

Enzyme Based Biocatalysis vs. Whole-Cell Biocatalysis... 

Kim J, Jia H, Wang P. Challenges in biocatalysis for enzyme-based biofuel cells. Biotechnol Adv 2006 24 296-308. 

The cholesterol-lowering drug atorvastatin, marketed as Lipitor, is an example where biocatalysis research has been applied extensively and is in industrial use. The enzyme 2-deoxyribose-5-phosphate aldolase (DERA) has been a target of directed evolution for the production of atorvastatin intermediates [8,9,71]. DeSantis and coworkers [8,9] used structure-based... 

The electrochemical rate constants for hydrogen peroxide reduction have been found to be dependent on the amount of Prussian blue deposited, confirming that H202 penetrates the films, and the inner layers of the polycrystal take part in the catalysis. For 4-6 nmol cm 2 of Prussian blue the electrochemical rate constant exceeds 0.01cm s-1 [12], which corresponds to the bi-molecular rate constant of kcat = 3 X 103 L mol 1s 1 [114], The rate constant of hydrogen peroxide reduction by ferrocyanide catalyzed by enzyme peroxidase was 2 X 104 L mol 1 s 1 [116]. Thus, the activity of the natural enzyme peroxidase is of a similar order of magnitude as the catalytic activity of our Prussian blue-based electrocatalyst. Due to the high catalytic activity and selectivity, which are comparable with biocatalysis, we were able to denote the specially deposited Prussian blue as an artificial peroxidase [114, 117]. 

Much of industrial chemistry takes place in organic solvents, or involves apolar compounds. Biocatalysis, in contrast, typically involves aqueous environments. Nevertheless, enzymes and microorganisms do in fact encounter apolar environments in Nature. Every cell is surrounded by at least one cell membrane, and more complex eukaryotic cells contain large amounts of intracellular membrane systems. These membranes consist of lipid bilayers into which many proteins are inserted present estimates, based on genomic information, are that about one-third of all proteins are membrane proteins, many of which are so-called intrinsic proteins that are intimately threaded through the apolar bilayer. These proteins are essentially dissolved in, and function partly within, an apolar phase. 

Biocatalysis has traditionally been performed in aqueous environments, but this is of limited value for the vast majority of nonpolar reactants used in chemical synthesis. For a long time it was assumed that all organic solvents act as denaturants, primarily based on the flawed extrapolation of data obtained from the exposure of aqueous solutions of enzyme to a few water-miscible solvents, such as alcohols and acetone, to that of all organic sol vents. 

A recent categorization of biotransformations by Pollard and Woodley (Figure 1.13), based on the availability of commercial enzymes, together with the examples given in this book demonstrate that biocatalysis can meet many of these pharmaceutical needs as shown by the highlighted entries in Table 1.3. 

An auspicious new strategy, in order to perform biocatalysis with hydrophobic substrates in w/o-microemulsion, is the usage of whole cells instead of purified enzymes [3,124,141]. There exist only a few surfactant-oil systems, in which whole cells are stable and suitable for a segmentation. Mainly the biodegradable surfactant based on sorbitan (Tween and Span) seems to be well suited for the solubilisation of whole cells in organic reaction media [142,143]. 

The first company based upon applied biocatalysis also dates back to the 19 century. In 1874 Christian Hansen started a company in Copenhagen, Denmark. His company— named Christian Hansen s Laboratory to this day—was the first in the industrial market with a standardized enzyme preparation, rennet, for cheese making. Rennet, a mixture of chymosin (also called rennin) and pepsin, was and still is obtained by salt extraction of the fonrth stomach of suckling calves. 

In some cases particular processes are espeeially important because of the value of the products produced and also the amounts of enzyme used, i.e. from both the enzyme producer and user standpoints. Therefore the examples on fructose syrups and 6-aminopenicillinic acid have been expanded to include much information on the business and technical strategies employed, and detailed proeess economic aspects respectively. Many other examples of biocatalysis-based commercial processes and products also exist with many others undergoing development. These other products also exhibit the same important technical and commercial features that are identified for the case studies in this chapter. 

HNLs comprise a heterogenous enzyme family, since hydroxynitrile lyase activity has evolved in different structural frames by convergent evolution [17, 18]. Thus, (S) -specific HNLs based on an a/P-hydrolase fold framework from Manihot esculmta (cassava) [19-21], Hevea hrasilensis (rubber tree) [22-26], and Sorghum hicolor (millet) [27-33] have been described. (R)-specific HNLs based on the structural framework of oxidoreductases were isolated from Linum usitatissimum (flax) [30, 34-37] and Rosaceae (e.g., bitter almonds) [31, 38]. Despite their potential in biocatalysis only few HNLs (from cassava and rubber tree) are available by recombinant gene expression, which is a prerequisite for their technical application [20, 24]. Thus, cloning, recombinant expression, and... 

---